Related Experiment Video

Updated: May 4, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cells

Yongshan Yao1, Shenghan Chen2, Xin Zhou1

  • 1Third Department of General Surgery, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei 443003, P.R. China.

Oncology Letters
|January 8, 2014
PubMed

Insights

Chemotherapy drugs like capecitabine and ixabepilone alter microRNA (miRNA) expression in triple-negative breast cancer (TNBC). This finding offers new insights into treatment mechanisms and potential diagnostic applications for breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Triple-negative breast cancer (TNBC) presents treatment challenges, particularly the luminal androgen receptor (LAR)-type.
  • Understanding chemotherapy mechanisms is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate novel chemotherapy mechanisms in LAR-type TNBC.
  • To explore the impact of capecitabine and ixabepilone on microRNA (miRNA) expression profiles.

Main Methods:

  • Analysis of miRNA expression profiles in LAR-type TNBC cells in vitro.
  • Treatment of cells with chemotherapy drugs: capecitabine and ixabepilone.
  • Quantitative assessment of specific miRNA level alterations.

Main Results:

  • Significant elevation of antitumor miRNAs (miR-122a, miR-145, miR-205) observed with 5-fluorouracil and ixabepilone treatment.
  • Downregulation of carcinogenic miR-296 and alterations in other miRNAs (miR-221, miR-210, miR-21, miR-10b) noted.
  • Chemotherapy drugs potentially exert effects via miRNA expression modulation.

Conclusions:

  • Chemotherapy efficacy in LAR-type TNBC may involve miRNA regulation.
  • miRNA expression profiles show potential as diagnostic and prognostic markers for breast cancer.
  • Provides a theoretical basis for integrating miRNA analysis into clinical breast cancer management.
Keywords:
5-FUixabepiloneluminal androgen receptor-typemicroRNAtriple-negative breast cancer

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

23.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81